Quarterly Report

CORCEPT THERAPEUTICS INC Filed 2026-11-03 Acc 0001628280-26-069501

Documents 1

2026-11-10 144 Sale of Securities
2026-11-04 4 See Remarks sold 25,000 shares at an average $81.85 ($2,046,351)
2026-11-04 4 President, Oncology sold 8,333 shares at an average $80.89 ($674,069)
2026-11-03 10-Q Quarterly Report
2026-11-03 8-K Results of operations · Regulation FD disclosure
2026-10-27 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-07-29 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading cort-20260930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…